Global COVID-19 Inactivated Vaccine Market Research Report 2020

Global COVID-19 Inactivated Vaccine Market Research Report 2020

May 2020 QYResearch ICT129 Pages Price :
$ 3900
This report focuses on the global COVID-19 Inactivated Vaccine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the COVID-19 Inactivated Vaccine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Inovio Pharmaceuticals
Takis Biotech (Evvivax)
Zydus Cadila
Codagenix, Inc.
GeoVax, Inc.
Bravovax
Janssen Pharmaceutical Companies
Altimmune
Vaxart
CanSino Biologics
ExpreS2ion Biotechnologies ApS
Clover Biopharmaceuticals
GSK
Vaxil Bio Ltd.
Generex
Novavax, Inc.
Sanofi Pasteur
Baylor
iBio, Inc.
Moderna, Inc.
Curevac
ImmunoPrecise

Market segment by Type, the product can be split into
In Clinical Trials
Out-of-Clinical Trials
Market segment by Application, split into
Hospital
Clinic
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global COVID-19 Inactivated Vaccine status, future forecast, growth opportunity, key market and key players.
To present the COVID-19 Inactivated Vaccine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of COVID-19 Inactivated Vaccine are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by COVID-19 Inactivated Vaccine Revenue
1.4 Market Analysis by Type
1.4.1 Global COVID-19 Inactivated Vaccine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 In Clinical Trials
1.4.3 Out-of-Clinical Trials
1.5 Market by Application
1.5.1 Global COVID-19 Inactivated Vaccine Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): COVID-19 Inactivated Vaccine Industry Impact
1.6.1 How the Covid-19 is Affecting the COVID-19 Inactivated Vaccine Industry
1.6.1.1 COVID-19 Inactivated Vaccine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and COVID-19 Inactivated Vaccine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for COVID-19 Inactivated Vaccine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 COVID-19 Inactivated Vaccine Market Perspective (2015-2026)
2.2 COVID-19 Inactivated Vaccine Growth Trends by Regions
2.2.1 COVID-19 Inactivated Vaccine Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 COVID-19 Inactivated Vaccine Historic Market Share by Regions (2018-2019)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Competition Landscape by Key Players
3.1 COVID-19 Inactivated Vaccine Revenue by Players (2019-2020)
3.2 COVID-19 Inactivated Vaccine Key Players Head office and Area Served
3.3 Key Players COVID-19 Inactivated Vaccine Product/Solution/Service
3.4 Date of Enter into COVID-19 Inactivated Vaccine Market
3.5 Key Players COVID-19 Inactivated Vaccine Funding/Investment Analysis
3.6 Global Key Players COVID-19 Inactivated Vaccine Valuation & Market Capitalization
3.7 Mergers & Acquisitions, Expansion Plans

4 Global COVID-19 Inactivated Vaccine Market Size by Type (2019-2026)

5 Global COVID-19 Inactivated Vaccine Market Size by Application (2019-2026)

6 North America
6.1 North America COVID-19 Inactivated Vaccine Market Forecast (2019-2026)
6.2 COVID-19 Inactivated Vaccine Key Players in North America (2019-2020)
6.3 North America COVID-19 Inactivated Vaccine Market Size by Type (2015-2020)
6.4 North America COVID-19 Inactivated Vaccine Market Size by Application (2015-2020)

7 Europe
7.1 Europe COVID-19 Inactivated Vaccine Market Forecast (2019-2026)
7.2 COVID-19 Inactivated Vaccine Key Players in Europe (2019-2020)
7.3 Europe COVID-19 Inactivated Vaccine Market Size by Type (2015-2020)
7.4 Europe COVID-19 Inactivated Vaccine Market Size by Application (2015-2020)

8 China
8.1 China COVID-19 Inactivated Vaccine Market Forecast (2019-2026)
8.2 COVID-19 Inactivated Vaccine Key Players in China (2019-2020)
8.3 China COVID-19 Inactivated Vaccine Market Size by Type (2015-2020)
8.4 China COVID-19 Inactivated Vaccine Market Size by Application (2015-2020)

9 Japan
9.1 Japan COVID-19 Inactivated Vaccine Market Forecast (2019-2026)
9.2 COVID-19 Inactivated Vaccine Key Players in Japan (2019-2020)
9.3 Japan COVID-19 Inactivated Vaccine Market Size by Type (2015-2020)
9.4 Japan COVID-19 Inactivated Vaccine Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia COVID-19 Inactivated Vaccine Market Forecast (2019-2026)
10.2 COVID-19 Inactivated Vaccine Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia COVID-19 Inactivated Vaccine Market Size by Type (2015-2020)
10.4 Southeast Asia COVID-19 Inactivated Vaccine Market Size by Application (2015-2020)

11 India
11.1 India COVID-19 Inactivated Vaccine Market Forecast (2019-2026)
11.2 COVID-19 Inactivated Vaccine Key Players in India (2019-2020)
11.3 India COVID-19 Inactivated Vaccine Market Size by Type (2015-2020)
11.4 India COVID-19 Inactivated Vaccine Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America COVID-19 Inactivated Vaccine Market Forecast (2019-2026)
12.2 COVID-19 Inactivated Vaccine Key Players in Central & South America (2019-2020)
12.3 Central & South America COVID-19 Inactivated Vaccine Market Size by Type (2015-2020)
12.4 Central & South America COVID-19 Inactivated Vaccine Market Size by Application (2015-2020)

13Key Players Profiles
13.1 Inovio Pharmaceuticals
13.1.1 Inovio Pharmaceuticals Company Details
13.1.2 Inovio Pharmaceuticals Business Overview and Its Total Revenue
13.1.3 Inovio Pharmaceuticals COVID-19 Inactivated Vaccine Introduction
13.1.4 Inovio Pharmaceuticals Revenue in COVID-19 Inactivated Vaccine Business (2019-2020))
13.1.5 Inovio Pharmaceuticals Recent Development
13.2 Takis Biotech (Evvivax)
13.2.1 Takis Biotech (Evvivax) Company Details
13.2.2 Takis Biotech (Evvivax) Business Overview and Its Total Revenue
13.2.3 Takis Biotech (Evvivax) COVID-19 Inactivated Vaccine Introduction
13.2.4 Takis Biotech (Evvivax) Revenue in COVID-19 Inactivated Vaccine Business (2019-2020))
13.2.5 Takis Biotech (Evvivax) Recent Development
13.3 Zydus Cadila
13.3.1 Zydus Cadila Company Details
13.3.2 Zydus Cadila Business Overview and Its Total Revenue
13.3.3 Zydus Cadila COVID-19 Inactivated Vaccine Introduction
13.3.4 Zydus Cadila Revenue in COVID-19 Inactivated Vaccine Business (2019-2020))
13.3.5 Zydus Cadila Recent Development
13.4 Codagenix, Inc.
13.4.1 Codagenix, Inc. Company Details
13.4.2 Codagenix, Inc. Business Overview and Its Total Revenue
13.4.3 Codagenix, Inc. COVID-19 Inactivated Vaccine Introduction
13.4.4 Codagenix, Inc. Revenue in COVID-19 Inactivated Vaccine Business (2019-2020))
13.4.5 Codagenix, Inc. Recent Development
13.5 GeoVax, Inc.
13.5.1 GeoVax, Inc. Company Details
13.5.2 GeoVax, Inc. Business Overview and Its Total Revenue
13.5.3 GeoVax, Inc. COVID-19 Inactivated Vaccine Introduction
13.5.4 GeoVax, Inc. Revenue in COVID-19 Inactivated Vaccine Business (2019-2020))
13.5.5 GeoVax, Inc. Recent Development
13.6 Bravovax
13.6.1 Bravovax Company Details
13.6.2 Bravovax Business Overview and Its Total Revenue
13.6.3 Bravovax COVID-19 Inactivated Vaccine Introduction
13.6.4 Bravovax Revenue in COVID-19 Inactivated Vaccine Business (2019-2020))
13.6.5 Bravovax Recent Development
13.7 Janssen Pharmaceutical Companies
13.7.1 Janssen Pharmaceutical Companies Company Details
13.7.2 Janssen Pharmaceutical Companies Business Overview and Its Total Revenue
13.7.3 Janssen Pharmaceutical Companies COVID-19 Inactivated Vaccine Introduction
13.7.4 Janssen Pharmaceutical Companies Revenue in COVID-19 Inactivated Vaccine Business (2019-2020))
13.7.5 Janssen Pharmaceutical Companies Recent Development
13.8 Altimmune
13.8.1 Altimmune Company Details
13.8.2 Altimmune Business Overview and Its Total Revenue
13.8.3 Altimmune COVID-19 Inactivated Vaccine Introduction
13.8.4 Altimmune Revenue in COVID-19 Inactivated Vaccine Business (2019-2020))
13.8.5 Altimmune Recent Development
13.9 Vaxart
13.9.1 Vaxart Company Details
13.9.2 Vaxart Business Overview and Its Total Revenue
13.9.3 Vaxart COVID-19 Inactivated Vaccine Introduction
13.9.4 Vaxart Revenue in COVID-19 Inactivated Vaccine Business (2019-2020))
13.9.5 Vaxart Recent Development
13.10 CanSino Biologics
13.10.1 CanSino Biologics Company Details
13.10.2 CanSino Biologics Business Overview and Its Total Revenue
13.10.3 CanSino Biologics COVID-19 Inactivated Vaccine Introduction
13.10.4 CanSino Biologics Revenue in COVID-19 Inactivated Vaccine Business (2019-2020))
13.10.5 CanSino Biologics Recent Development
13.11 ExpreS2ion Biotechnologies ApS
10.11.1 ExpreS2ion Biotechnologies ApS Company Details
10.11.2 ExpreS2ion Biotechnologies ApS Business Overview and Its Total Revenue
10.11.3 ExpreS2ion Biotechnologies ApS COVID-19 Inactivated Vaccine Introduction
10.11.4 ExpreS2ion Biotechnologies ApS Revenue in COVID-19 Inactivated Vaccine Business (2019-2020))
10.11.5 ExpreS2ion Biotechnologies ApS Recent Development
13.12 Clover Biopharmaceuticals
10.12.1 Clover Biopharmaceuticals Company Details
10.12.2 Clover Biopharmaceuticals Business Overview and Its Total Revenue
10.12.3 Clover Biopharmaceuticals COVID-19 Inactivated Vaccine Introduction
10.12.4 Clover Biopharmaceuticals Revenue in COVID-19 Inactivated Vaccine Business (2019-2020))
10.12.5 Clover Biopharmaceuticals Recent Development
13.13 GSK
10.13.1 GSK Company Details
10.13.2 GSK Business Overview and Its Total Revenue
10.13.3 GSK COVID-19 Inactivated Vaccine Introduction
10.13.4 GSK Revenue in COVID-19 Inactivated Vaccine Business (2019-2020))
10.13.5 GSK Recent Development
13.14 Vaxil Bio Ltd.
10.14.1 Vaxil Bio Ltd. Company Details
10.14.2 Vaxil Bio Ltd. Business Overview and Its Total Revenue
10.14.3 Vaxil Bio Ltd. COVID-19 Inactivated Vaccine Introduction
10.14.4 Vaxil Bio Ltd. Revenue in COVID-19 Inactivated Vaccine Business (2019-2020))
10.14.5 Vaxil Bio Ltd. Recent Development
13.15 Generex
10.15.1 Generex Company Details
10.15.2 Generex Business Overview and Its Total Revenue
10.15.3 Generex COVID-19 Inactivated Vaccine Introduction
10.15.4 Generex Revenue in COVID-19 Inactivated Vaccine Business (2019-2020))
10.15.5 Generex Recent Development
13.16 Novavax, Inc.
10.16.1 Novavax, Inc. Company Details
10.16.2 Novavax, Inc. Business Overview and Its Total Revenue
10.16.3 Novavax, Inc. COVID-19 Inactivated Vaccine Introduction
10.16.4 Novavax, Inc. Revenue in COVID-19 Inactivated Vaccine Business (2019-2020))
10.16.5 Novavax, Inc. Recent Development
13.17 Sanofi Pasteur
10.17.1 Sanofi Pasteur Company Details
10.17.2 Sanofi Pasteur Business Overview and Its Total Revenue
10.17.3 Sanofi Pasteur COVID-19 Inactivated Vaccine Introduction
10.17.4 Sanofi Pasteur Revenue in COVID-19 Inactivated Vaccine Business (2019-2020))
10.17.5 Sanofi Pasteur Recent Development
13.18 Baylor
10.18.1 Baylor Company Details
10.18.2 Baylor Business Overview and Its Total Revenue
10.18.3 Baylor COVID-19 Inactivated Vaccine Introduction
10.18.4 Baylor Revenue in COVID-19 Inactivated Vaccine Business (2019-2020))
10.18.5 Baylor Recent Development
13.19 iBio, Inc.
10.19.1 iBio, Inc. Company Details
10.19.2 iBio, Inc. Business Overview and Its Total Revenue
10.19.3 iBio, Inc. COVID-19 Inactivated Vaccine Introduction
10.19.4 iBio, Inc. Revenue in COVID-19 Inactivated Vaccine Business (2019-2020))
10.19.5 iBio, Inc. Recent Development
13.20 Moderna, Inc.
10.20.1 Moderna, Inc. Company Details
10.20.2 Moderna, Inc. Business Overview and Its Total Revenue
10.20.3 Moderna, Inc. COVID-19 Inactivated Vaccine Introduction
10.20.4 Moderna, Inc. Revenue in COVID-19 Inactivated Vaccine Business (2019-2020))
10.20.5 Moderna, Inc. Recent Development
13.21 Curevac
10.21.1 Curevac Company Details
10.21.2 Curevac Business Overview and Its Total Revenue
10.21.3 Curevac COVID-19 Inactivated Vaccine Introduction
10.21.4 Curevac Revenue in COVID-19 Inactivated Vaccine Business (2019-2020))
10.21.5 Curevac Recent Development
13.22 ImmunoPrecise
10.22.1 ImmunoPrecise Company Details
10.22.2 ImmunoPrecise Business Overview and Its Total Revenue
10.22.3 ImmunoPrecise COVID-19 Inactivated Vaccine Introduction
10.22.4 ImmunoPrecise Revenue in COVID-19 Inactivated Vaccine Business (2019-2020))
10.22.5 ImmunoPrecise Recent Development

14 Market Dynamics
14.1 Drivers
14.2 Challenges
14.3 Porters Five Forces Analysis
14.4 Market Ecosystem and Value Chain Analysis

15 Key Findings in This Report
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Table

List of Tables
Table 1. COVID-19 Inactivated Vaccine Key Market Segments
Table 2. Key Players Covered: Ranking by COVID-19 Inactivated Vaccine Revenue
Table 3. Ranking of Global Top COVID-19 Inactivated Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global COVID-19 Inactivated Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of In Clinical Trials
Table 6. Key Players of Out-of-Clinical Trials
Table 7. COVID-19 Impact Global Market: (Four COVID-19 Inactivated Vaccine Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for COVID-19 Inactivated Vaccine Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for COVID-19 Inactivated Vaccine Players to Combat Covid-19 Impact
Table 12. Global COVID-19 Inactivated Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global COVID-19 Inactivated Vaccine Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global COVID-19 Inactivated Vaccine Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global COVID-19 Inactivated Vaccine Market Share by Regions 2019-2026
Table 16. Market Top Trends
Table 17. Market Use Cases
Table 18. Global COVID-19 Inactivated Vaccine Revenue by Players (2019-2020) (Million US$)
Table 19. Global COVID-19 Inactivated Vaccine Market Share by Players (2019-2020)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players COVID-19 Inactivated Vaccine Product Solution and Service
Table 22. Date of Enter into COVID-19 Inactivated Vaccine Market
Table 23. Global Key Players COVID-19 Inactivated Vaccine Funding/Investment Analysis (Million USD)
Table 24. Global Key Players COVID-19 Inactivated Vaccine Valuation & Market Capitalization (Million USD)
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global COVID-19 Inactivated Vaccine Market Size by Type (2019-2026) (Million US$)
Table 27. Global COVID-19 Inactivated Vaccine Market Size Share by Type (2019-2026)
Table 28. Global COVID-19 Inactivated Vaccine Market Size by Application (2019-2026) (Million US$)
Table 29. Global COVID-19 Inactivated Vaccine Market Size Share by Application (2019-2026)
Table 30. North America Key Players COVID-19 Inactivated Vaccine Revenue (2019-2020) (Million US$)
Table 31. North America Key Players COVID-19 Inactivated Vaccine Market Share (2019-2020)
Table 32. North America COVID-19 Inactivated Vaccine Market Size by Type (2019-2026) (Million US$)
Table 33. North America COVID-19 Inactivated Vaccine Market Share by Type (2019-2026)
Table 34. North America COVID-19 Inactivated Vaccine Market Size by Application (2019-2026) (Million US$)
Table 35. North America COVID-19 Inactivated Vaccine Market Share by Application (2019-2026)
Table 36. Europe Key Players COVID-19 Inactivated Vaccine Revenue (2019-2020) (Million US$)
Table 37. Europe Key Players COVID-19 Inactivated Vaccine Market Share (2019-2020)
Table 38. Europe COVID-19 Inactivated Vaccine Market Size by Type (2019-2026) (Million US$)
Table 39. Europe COVID-19 Inactivated Vaccine Market Share by Type (2019-2026)
Table 40. Europe COVID-19 Inactivated Vaccine Market Size by Application (2019-2026) (Million US$)
Table 41. Europe COVID-19 Inactivated Vaccine Market Share by Application (2019-2026)
Table 42. China Key Players COVID-19 Inactivated Vaccine Revenue (2019-2020) (Million US$)
Table 43. China Key Players COVID-19 Inactivated Vaccine Market Share (2019-2020)
Table 44. China COVID-19 Inactivated Vaccine Market Size by Type (2019-2026) (Million US$)
Table 45. China COVID-19 Inactivated Vaccine Market Share by Type (2019-2026)
Table 46. China COVID-19 Inactivated Vaccine Market Size by Application (2019-2026) (Million US$)
Table 47. China COVID-19 Inactivated Vaccine Market Share by Application (2019-2026)
Table 48. Japan Key Players COVID-19 Inactivated Vaccine Revenue (2019-2020) (Million US$)
Table 49. Japan Key Players COVID-19 Inactivated Vaccine Market Share (2019-2020)
Table 50. Japan COVID-19 Inactivated Vaccine Market Size by Type (2019-2026) (Million US$)
Table 51. Japan COVID-19 Inactivated Vaccine Market Share by Type (2019-2026)
Table 52. Japan COVID-19 Inactivated Vaccine Market Size by Application (2019-2026) (Million US$)
Table 53. Japan COVID-19 Inactivated Vaccine Market Share by Application (2019-2026)
Table 54. Southeast Asia Key Players COVID-19 Inactivated Vaccine Revenue (2019-2020) (Million US$)
Table 55. Southeast Asia Key Players COVID-19 Inactivated Vaccine Market Share (2019-2020)
Table 56. Southeast Asia COVID-19 Inactivated Vaccine Market Size by Type (2019-2026) (Million US$)
Table 57. Southeast Asia COVID-19 Inactivated Vaccine Market Share by Type (2019-2026)
Table 58. Southeast Asia COVID-19 Inactivated Vaccine Market Size by Application (2019-2026) (Million US$)
Table 59. Southeast Asia COVID-19 Inactivated Vaccine Market Share by Application (2019-2026)
Table 60. India Key Players COVID-19 Inactivated Vaccine Revenue (2019-2020) (Million US$)
Table 61. India Key Players COVID-19 Inactivated Vaccine Market Share (2019-2020)
Table 62. India COVID-19 Inactivated Vaccine Market Size by Type (2019-2026) (Million US$)
Table 63. India COVID-19 Inactivated Vaccine Market Share by Type (2019-2026)
Table 64. India COVID-19 Inactivated Vaccine Market Size by Application (2019-2026) (Million US$)
Table 65. India COVID-19 Inactivated Vaccine Market Share by Application (2019-2026)
Table 66. Central & South America Key Players COVID-19 Inactivated Vaccine Revenue (2019-2020) (Million US$)
Table 67. Central & South America Key Players COVID-19 Inactivated Vaccine Market Share (2019-2020)
Table 68. Central & South America COVID-19 Inactivated Vaccine Market Size by Type (2019-2026) (Million US$)
Table 69. Central & South America COVID-19 Inactivated Vaccine Market Share by Type (2019-2026)
Table 70. Central & South America COVID-19 Inactivated Vaccine Market Size by Application (2019-2026) (Million US$)
Table 71. Central & South America COVID-19 Inactivated Vaccine Market Share by Application (2019-2026)
Table 72. Inovio Pharmaceuticals Company Details
Table 73. Inovio Pharmaceuticals Business Overview
Table 74. Inovio Pharmaceuticals Product
Table 75. Company Description and Business Overview
Table 76. Inovio Pharmaceuticals COVID-19 Inactivated Vaccine Product
Table 77. Inovio Pharmaceuticals Revenue in COVID-19 Inactivated Vaccine Business 2019 and 2020 (Million US$)
Table 78. Inovio Pharmaceuticals Recent Development
Table 79. Takis Biotech (Evvivax) Company Details
Table 80. Takis Biotech (Evvivax) Business Overview
Table 81. Takis Biotech (Evvivax) Product
Table 82. Company Description and Business Overview
Table 83. Takis Biotech (Evvivax) COVID-19 Inactivated Vaccine Product
Table 84. Takis Biotech (Evvivax) Revenue in COVID-19 Inactivated Vaccine Business 2019 and 2020 (Million US$)
Table 85. Takis Biotech (Evvivax) Recent Development
Table 86. Zydus Cadila Company Details
Table 87. Zydus Cadila Business Overview
Table 88. Zydus Cadila Product
Table 89. Company Description and Business Overview
Table 90. Zydus Cadila COVID-19 Inactivated Vaccine Product
Table 91. Zydus Cadila Revenue in COVID-19 Inactivated Vaccine Business 2019 and 2020 (Million US$)
Table 92. Zydus Cadila Recent Development
Table 93. Codagenix, Inc. Company Details
Table 94. Codagenix, Inc. Business Overview
Table 95. Codagenix, Inc. Product
Table 96. Company Description and Business Overview
Table 97. Codagenix, Inc. COVID-19 Inactivated Vaccine Product
Table 98. Codagenix, Inc. Revenue in COVID-19 Inactivated Vaccine Business 2019 and 2020 (Million US$)
Table 99. Codagenix, Inc. Recent Development
Table 100. GeoVax, Inc. Company Details
Table 101. GeoVax, Inc. Business Overview
Table 102. GeoVax, Inc. Product
Table 103. Company Description and Business Overview
Table 104. GeoVax, Inc. COVID-19 Inactivated Vaccine Product
Table 105. GeoVax, Inc. Revenue in COVID-19 Inactivated Vaccine Business 2019 and 2020 (Million US$)
Table 106. GeoVax, Inc. Recent Development
Table 107. Bravovax Company Details
Table 108. Bravovax Business Overview
Table 109. Bravovax Product
Table 110. Company Description and Business Overview
Table 111. Bravovax COVID-19 Inactivated Vaccine Product
Table 112. Bravovax Revenue in COVID-19 Inactivated Vaccine Business 2019 and 2020 (Million US$)
Table 113. Bravovax Recent Development
Table 114. Janssen Pharmaceutical Companies Company Details
Table 115. Janssen Pharmaceutical Companies Business Overview
Table 116. Janssen Pharmaceutical Companies Product
Table 117. Company Description and Business Overview
Table 118. Janssen Pharmaceutical Companies COVID-19 Inactivated Vaccine Product
Table 119. Janssen Pharmaceutical Companies Revenue in COVID-19 Inactivated Vaccine Business 2019 and 2020 (Million US$)
Table 120. Janssen Pharmaceutical Companies Recent Development
Table 121. Altimmune Business Overview
Table 122. Altimmune Product
Table 123. Altimmune Company Details
Table 124. Company Description and Business Overview
Table 125. Altimmune COVID-19 Inactivated Vaccine Product
Table 126. Altimmune Revenue in COVID-19 Inactivated Vaccine Business 2019 and 2020 (Million US$)
Table 127. Altimmune Recent Development
Table 128. Vaxart Company Details
Table 129. Vaxart Business Overview
Table 130. Vaxart Product
Table 131. Company Description and Business Overview
Table 132. Vaxart COVID-19 Inactivated Vaccine Product
Table 133. Vaxart Revenue in COVID-19 Inactivated Vaccine Business 2019 and 2020 (Million US$)
Table 134. Vaxart Recent Development
Table 135. CanSino Biologics Company Details
Table 136. CanSino Biologics Business Overview
Table 137. CanSino Biologics Product
Table 138. Company Description and Business Overview
Table 139. CanSino Biologics COVID-19 Inactivated Vaccine Product
Table 140. CanSino Biologics Revenue in COVID-19 Inactivated Vaccine Business 2019 and 2020 (Million US$)
Table 141. CanSino Biologics Recent Development
Table 142. ExpreS2ion Biotechnologies ApS Company Details
Table 143. ExpreS2ion Biotechnologies ApS Business Overview
Table 144. ExpreS2ion Biotechnologies ApS Product
Table 145. Company Description and Business Overview
Table 146. ExpreS2ion Biotechnologies ApS COVID-19 Inactivated Vaccine Product
Table 147. ExpreS2ion Biotechnologies ApS Revenue in COVID-19 Inactivated Vaccine Business 2019 and 2020 (Million US$)
Table 148. ExpreS2ion Biotechnologies ApS Recent Development
Table 149. Clover Biopharmaceuticals Company Details
Table 150. Clover Biopharmaceuticals Business Overview
Table 151. Clover Biopharmaceuticals Product
Table 152. Company Description and Business Overview
Table 153. Clover Biopharmaceuticals COVID-19 Inactivated Vaccine Product
Table 154. Clover Biopharmaceuticals Revenue in COVID-19 Inactivated Vaccine Business 2019 and 2020 (Million US$)
Table 155. Clover Biopharmaceuticals Recent Development
Table 156. GSK Company Details
Table 157. GSK Business Overview
Table 158. GSK Product
Table 159. Company Description and Business Overview
Table 160. GSK COVID-19 Inactivated Vaccine Product
Table 161. GSK Revenue in COVID-19 Inactivated Vaccine Business 2019 and 2020 (Million US$)
Table 162. GSK Recent Development
Table 163. Vaxil Bio Ltd. Company Details
Table 164. Vaxil Bio Ltd. Business Overview
Table 165. Vaxil Bio Ltd. Product
Table 166. Company Description and Business Overview
Table 167. Vaxil Bio Ltd. COVID-19 Inactivated Vaccine Product
Table 168. Vaxil Bio Ltd. Revenue in COVID-19 Inactivated Vaccine Business 2019 and 2020 (Million US$)
Table 169. Vaxil Bio Ltd. Recent Development
Table 170. Generex Company Details
Table 171. Generex Business Overview
Table 172. Generex Product
Table 173. Company Description and Business Overview
Table 174. Generex COVID-19 Inactivated Vaccine Product
Table 175. Generex Revenue in COVID-19 Inactivated Vaccine Business 2019 and 2020 (Million US$)
Table 176. Generex Recent Development
Table 177. Novavax, Inc. Company Details
Table 178. Novavax, Inc. Business Overview
Table 179. Novavax, Inc. Product
Table 180. Company Description and Business Overview
Table 181. Novavax, Inc. COVID-19 Inactivated Vaccine Product
Table 182. Novavax, Inc. Revenue in COVID-19 Inactivated Vaccine Business 2019 and 2020 (Million US$)
Table 183. Novavax, Inc. Recent Development
Table 184. Sanofi Pasteur Company Details
Table 185. Sanofi Pasteur Business Overview
Table 186. Sanofi Pasteur Product
Table 187. Company Description and Business Overview
Table 188. Sanofi Pasteur COVID-19 Inactivated Vaccine Product
Table 189. Sanofi Pasteur Revenue in COVID-19 Inactivated Vaccine Business 2019 and 2020 (Million US$)
Table 190. Sanofi Pasteur Recent Development
Table 191. Baylor Company Details
Table 192. Baylor Business Overview
Table 193. Baylor Product
Table 194. Company Description and Business Overview
Table 195. Baylor COVID-19 Inactivated Vaccine Product
Table 196. Baylor Revenue in COVID-19 Inactivated Vaccine Business 2019 and 2020 (Million US$)
Table 197. Baylor Recent Development
Table 198. iBio, Inc. Company Details
Table 199. iBio, Inc. Business Overview
Table 200. iBio, Inc. Product
Table 201. Company Description and Business Overview
Table 202. iBio, Inc. COVID-19 Inactivated Vaccine Product
Table 203. iBio, Inc. Revenue in COVID-19 Inactivated Vaccine Business 2019 and 2020 (Million US$)
Table 204. iBio, Inc. Recent Development
Table 205. Moderna, Inc. Company Details
Table 206. Moderna, Inc. Business Overview
Table 207. Moderna, Inc. Product
Table 208. Company Description and Business Overview
Table 209. Moderna, Inc. COVID-19 Inactivated Vaccine Product
Table 210. Moderna, Inc. Revenue in COVID-19 Inactivated Vaccine Business 2019 and 2020 (Million US$)
Table 211. Moderna, Inc. Recent Development
Table 212. Curevac Company Details
Table 213. Curevac Business Overview
Table 214. Curevac Product
Table 215. Company Description and Business Overview
Table 216. Curevac COVID-19 Inactivated Vaccine Product
Table 217. Curevac Revenue in COVID-19 Inactivated Vaccine Business 2019 and 2020 (Million US$)
Table 218. Curevac Recent Development
Table 219. ImmunoPrecise Company Details
Table 220. ImmunoPrecise Business Overview
Table 221. ImmunoPrecise Product
Table 222. Company Description and Business Overview
Table 223. ImmunoPrecise COVID-19 Inactivated Vaccine Product
Table 224. ImmunoPrecise Revenue in COVID-19 Inactivated Vaccine Business 2019 and 2020 (Million US$)
Table 225. ImmunoPrecise Recent Development
Table 226. Company Description and Business Overview
Table 227. Company Description and Business Overview
Table 228. Company Description and Business Overview
Table 229. Company Description and Business Overview
Table 230. Company Description and Business Overview
Table 231. Company Description and Business Overview
Table 232. Company Description and Business Overview
Table 233. Company Description and Business Overview
Table 234. Company Description and Business Overview
Table 235. Company Description and Business Overview
Table 236. Company Description and Business Overview
Table 237. Company Description and Business Overview
Table 238. Company Description and Business Overview
Table 239. Company Description and Business Overview
Table 240. Company Description and Business Overview
Table 241. Company Description and Business Overview
Table 242. Company Description and Business Overview
Table 243. Company Description and Business Overview
Table 244. Key Drivers: Impact Analysis (2021-2026)
Table 245. Key Opportunities
Table 246. Key Challenges
Table 247. Research Programs/Design for This Report
Table 248. Key Data Information from Secondary Sources
Table 249. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COVID-19 Inactivated Vaccine Market Share by Type: 2020 VS 2026
Figure 2. In Clinical Trials Features
Figure 3. Out-of-Clinical Trials Features
Figure 4. Global COVID-19 Inactivated Vaccine Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. COVID-19 Inactivated Vaccine Report Years Considered
Figure 9. Global COVID-19 Inactivated Vaccine and Growth Rate (2019-2026) (Million US$)
Figure 10. Global COVID-19 Inactivated Vaccine Market Share by Regions (2019-2026)
Figure 11. Global COVID-19 Inactivated Vaccine Market Share by Players in 2019
Figure 12. Global COVID-19 Inactivated Vaccine Market Size Market Share by Type (2019-2026)
Figure 13. Global COVID-19 Inactivated Vaccine Market Size Market Share by Application (2019-2026)
Figure 14. North America COVID-19 Inactivated Vaccine Market Size YoY Growth (2019-2026) (Million US$)
Figure 15. Europe COVID-19 Inactivated Vaccine Market Size YoY Growth (2019-2026) (Million US$)
Figure 16. China COVID-19 Inactivated Vaccine Market Size YoY Growth (2019-2026) (Million US$)
Figure 17. Japan COVID-19 Inactivated Vaccine Market Size YoY Growth (2019-2026) (Million US$)
Figure 18. Southeast Asia COVID-19 Inactivated Vaccine Market Size YoY Growth (2019-2026) (Million US$)
Figure 19. India COVID-19 Inactivated Vaccine Market Size YoY Growth (2019-2026) (Million US$)
Figure 20. Central & South America COVID-19 Inactivated Vaccine Market Size YoY Growth (2019-2026) (Million US$)
Figure 21. Bottom-up and Top-down Approaches for This Report
Figure 22. Data Triangulation
Figure 23. Key Executives Interviewed

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 3900
$ 5850

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top